Category: Boston Scientific
A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.
The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.
The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.
Sales of its cardiac rhythm management devices help boost Boston Scientific above expectations for the 3rd quarter.
Boston Scientific says its CoverEdge 32 and CoverEdge X 32 surgical leads won CE Mark approval in the European Union and pre-market approval from the FDA for use with its Precision Spectra spinal cord stimulator.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA yanks enhancement reporting requirement; FDA approves Medtronic's full-body MRI-safe lead; FDA strikes out again in Prevor drug-or-device case; Abbott inks co-distribution deal with Carl Zeiss Meditec; Boston Scientific wins CE Mark for Accolade MRI-safe pacemakers
A former Boston Scientific engineer, Aaron Khieu, is indicted on charges of stealing balloon catheter trade secrets from Boston Scientific, including the specs for an as-yet-unreleased device, and planning to use them to start his own company in Vietnam.
Boston Scientific launches a clinical trial examining outcomes in underserved populations with its Promus Premier drug-eluting stent.